Close Menu
    What's Hot

    Editor’s Letter – Volume 2, Issue 5, May 2026

    May 13, 2026

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      Daiichi Life to Reinsure Whole Life Block with Prismic Life

      April 13, 2026

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026
      Just Group

      Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

      May 11, 2026

      Bakkavor Pension Scheme Completes Bulk Purchase Annuity Buy-In With Rothesay

      May 5, 2026
      Bank of England

      Prudential Regulation Authority Publishes New Funded Reinsurance Regulations

      April 29, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026

      UK Equity Release Market Origination Slows To Begin 2026

      May 6, 2026

      CHIP Mortgage Trust Issues C$200m of Medium-Term Notes

      April 29, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Questions Over UK Pension Risk Transfer Market as Government Mulls Defined Benefit Pension Surplus Changes

    Longevity and Mortality Risk Transfer March 13, 2025By Mark McCord
    Share
    Twitter LinkedIn Email

    UK Chancellor of the Exchequer Rachel Reeves’ announcement at the end of January that she wants to unshackle billions of pounds locked in defined benefit (DB) pension fund surpluses has raised questions about how such a move might impact the country’s bulk purchase annuity market. 

    Reeves told a meeting of City chiefs that by releasing the money “trapped” in DB pensions, employers could allocate it to potentially more lucrative strategies outside of their scheme investment remits. 

    Surpluses are tied into schemes by rules agreed between sponsors and trustees. If the Chancellor loosens those rules, employers may be encouraged to run their schemes on, slowing growth in the bulk annuity market from which insurers are benefiting. 

    “These [new] rules might make it easier for a sponsor to access surpluses whilst the scheme is still running on or use it in a different way, such as for DC contributions,” said Lara Desay, Hymans Roberston’s recently appointed Head of Risk Transfer.  

    Reeves’ proposal has the backing of The Pensions Regulator whose Chief Executive, Nausicaa Delfas, said it “supports efforts to help trustees and employers consider how to safely release surplus if it can improve member benefits or unlock investment in the wider economy”. 

    The motivation for changing the rules around surpluses is clear. About 75% of DB schemes are fully funded with around $226bn of surpluses at the end of January, according to the PPF 7800 Index. That money could provide plenty of ammunition for the Chancellor’s hopes of stimulating the UK’s economy. 

    The implications can be positive for sponsors and trustees alike. Employers will have new funds to support growth and investment initiatives, while scheme members could see some of the released capital ploughed back into the scheme benefit schedules or put into defined contribution (DC) schemes. 

    Just how beneficial any move might be would depend on the detailed wording of any proposal. A draft is expected after a consultation that’s slated for the spring. For many schemes, however, this isn’t even an option: only those that struck agreements before 2016 are entitled to begin the process of early access to surpluses.  

    Already, at least two major companies have announced run-ons since the Chancellor’s announcement. In March, global investor Aberdeen agreed a plan with trustees to access £800m of DB scheme surpluses. That followed a decision by Schroders to run-on its scheme in January. 

    A change that could benefit the risk-offset industry is a redrawing of the tax code associated with wound-down schemes. Full buy-outs carry a tax implication that can outweigh the cost benefits of winding down. Although previous chancellor Jeremy Hunt lowered the tax rate to 25% from 35%, it’s still regarded as penal, especially for smaller schemes. If Reeves introduces a lower tax rate, the cost of wind down relative to that of running-on a scheme would be reduced and potentially drive more business to bulk annuity providers. 

    The likelihood of a shift either way, however, hinges on a variety of factors as well as the peculiarities of each scheme. While sponsors may be encouraged to run-on if the Chancellor creates a climate more favourable to doing so, they will still need the support of trustees. That could be forthcoming with incentives such as pledging to use substantial proportions of those funds to top-up DB contributions, enhance benefits or fund DC schemes. Both the Aberdeen and Schroders deals, for example, were focussed on releasing surpluses, in part, to fund DC contributions. 

    Covenants written into schemes differ, too, and where they place less emphasis on sharing returned surpluses to members, trustee appetite for a run-on is likely to be minimal. As well, a run-on under better terms may still be more expensive to administer for smaller schemes, which don’t have the economies of scale to maximise returns from, or balance the risks to, their members’ contributions. 

    “For the most part, unless there is a particularly strong sponsor covenant in place, trustees are generally targeting the insurance market – it’s the sponsor that is driving the run-on discussion,” Desay said. 

    “If you can afford to buy-in/buy-out that is likely to remain the option of choice at the smaller end of the market.” 

    Desay also doubts whether other pension developments introduced recently, including the CDC scheme, is likely alter the trend towards buy-outs and wind-downs. 

    The promise of reinvesting in the company is likely to be a greater incentive to sponsors than the opportunity to invest elsewhere. With restrictions on schemes’ investment strategies already limited, industry figures have questioned how much more capital sponsors would allocate to other assets.    

    “It’s been somewhat lost in the debate so far that bulk annuity providers already invest tens of billions in productive assets in the UK,” said Frankie Borrell, Head of BPA Origination at Royal London.  

    Offset deals represent a small part of insurers’ business but it is a market that has been growing for a decade. Willis Towers Watson forecasts that £50bn of bulk annuity transactions will be completed in 2025, which will be supplemented by £20bn of longevity risk deals, a market that it said is likely to benefit from any loosening of surplus return rules. 

    Insurers hope any measures Reeves introduces will do little to halt growth in a market that Royal London’s Borrell said had seen thousands of buy-ins by bulk annuity providers give millions of members of DB pension schemes financial security. 

    “Whilst it is often the multi-billion-pound transactions that attract the headlines, beneath the surface there is a highly functioning and competitive marketplace with all segments being well serviced by the ten active bulk annuity providers,” Borrell said.  

    “Buy-out and wind-up of a DB pension scheme also crucially removes funding risk and delivers improved operational freedom for the companies that sponsor them.” 

    He stressed the need for to ensure protections to scheme funding levels under any new rules, a sentiment that pension and insurance industry advocates alike support. The Aberdeen deal struck in March came with stringent guardrails to ensure that the security and funding position of the DB scheme was not affected, for example. 

    Borrell warned, however, that unless carefully implemented, change could come unintended consequences. 

    “Many trustees and corporate sponsors of pension schemes remember all too well the surpluses and contribution holidays that were enjoyed in the 1990s, only for the situation to reverse into a ‘deficit migraine’ for over 20 years,” he said.  

    “The government would better meet their objectives through supporting the thriving bulk annuity market whilst providing the right investment opportunities to insurers, that they can naturally invest in at scale and more efficiently than most pension schemes.” 

    2025 - March Longevity Risk Pension Risk Transfer Volume 4 Issue 3 - March 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026By Mark McCord

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026By Greg Winterton

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026By Dr. Jyotsna Kamble
    Just Group

    Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

    May 11, 2026By LMI Newsdesk
    Latest Issue

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.